JAK-话题@MedSci

#JAK#

115篇内容 | 2654人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1737993, encodeId=c9a61e37993ea, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=礼来JAK抑制剂Olumiant治疗系统性红斑狼疮的2期临床试验获得成功, objectType=article, longId=145138, objectId=96a9145138b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96a9145138b2, replyNumber=0, likeNumber=71, createdTime=2019-04-23, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96a9145138b2, moduleTitle=礼来JAK抑制剂Olumiant治疗系统性红斑狼疮的2期临床试验获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96a9145138b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737994, encodeId=78e91e3799464, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Stem cells：JAK2V617F突变型巨核细胞可通过促血小板生成素/MPL信号促进造血干/祖细胞扩增, objectType=article, longId=145699, objectId=3bde145699a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bde145699a3, replyNumber=0, likeNumber=79, createdTime=2018-11-21, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bde145699a3, moduleTitle=Stem cells：JAK2V617F突变型巨核细胞可通过促血小板生成素/MPL信号促进造血干/祖细胞扩增, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bde145699a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737999, encodeId=b5d71e379994c, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=JCC： JAK激酶抑制剂Peficitinib在治疗中重度UC中有良好效果, objectType=article, longId=153224, objectId=b6d91532243b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6d91532243b, replyNumber=0, likeNumber=55, createdTime=2019-01-25, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6d91532243b, moduleTitle=JCC： JAK激酶抑制剂Peficitinib在治疗中重度UC中有良好效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6d91532243b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737996, encodeId=1b061e3799686, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=CLIN CANCER RES：MET致癌活化和JAK2失活会影响肺癌PD-L1表达, objectType=article, longId=150102, objectId=1ff11501029e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ff11501029e, replyNumber=0, likeNumber=71, createdTime=2019-07-02, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ff11501029e, moduleTitle=CLIN CANCER RES：MET致癌活化和JAK2失活会影响肺癌PD-L1表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ff11501029e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737984, encodeId=05f61e37984fe, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Blood：PI3Kδ抑制剂（INCB040093）单独或联合JAK1抑制剂（itacitinib）用于复发性/难治性B细胞淋巴瘤的安全性和疗效研究, objectType=article, longId=136587, objectId=884f13658e71, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=884f13658e71, replyNumber=0, likeNumber=70, createdTime=2018-09-19, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=884f13658e71, moduleTitle=Blood：PI3Kδ抑制剂（INCB040093）单独或联合JAK1抑制剂（itacitinib）用于复发性/难治性B细胞淋巴瘤的安全性和疗效研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=884f13658e71)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737982, encodeId=d4c71e3798283, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Blood：JAK2抑制剂用于治疗骨髓增生性肿瘤（MFN）的效果和安全性评估, objectType=article, longId=135312, objectId=411e1353128b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=411e1353128b, replyNumber=0, likeNumber=75, createdTime=2018-06-24, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=411e1353128b, moduleTitle=Blood：JAK2抑制剂用于治疗骨髓增生性肿瘤（MFN）的效果和安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=411e1353128b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737992, encodeId=29891e3799261, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=NEJM：扎心了！治疗骨髓纤维化的JAK2抑制剂竟会导致淋巴瘤！, objectType=article, longId=141213, objectId=82cd14121391, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82cd14121391, replyNumber=0, likeNumber=77, createdTime=2018-08-15, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82cd14121391, moduleTitle=NEJM：扎心了！治疗骨髓纤维化的JAK2抑制剂竟会导致淋巴瘤！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82cd14121391)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737990, encodeId=939c1e37990b8, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状, objectType=article, longId=140780, objectId=68e0140e800a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68e0140e800a, replyNumber=0, likeNumber=66, createdTime=2018-12-13, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68e0140e800a, moduleTitle=Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68e0140e800a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737998, encodeId=0f251e37998f1, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Blood：Jak2V617F协同Dnmt3a缺失通过激活增强子驱动的炎症信号诱导骨髓纤维化, objectType=article, longId=151989, objectId=768d15198901, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=768d15198901, replyNumber=0, likeNumber=49, createdTime=2019-09-13, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=768d15198901, moduleTitle=Blood：Jak2V617F协同Dnmt3a缺失通过激活增强子驱动的炎症信号诱导骨髓纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=768d15198901)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737997, encodeId=e59f1e37997d2, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=瑞石生物开展新型JAK1抑制剂全球同步临床研究, objectType=article, longId=151586, objectId=c4e61515866b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4e61515866b, replyNumber=0, likeNumber=54, createdTime=2019-05-12, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4e61515866b, moduleTitle=瑞石生物开展新型JAK1抑制剂全球同步临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4e61515866b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737988, encodeId=de6c1e37988d0, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Neurology：病例：Creutzfeldt-Jakob病的DWI和脑电图表现, objectType=article, longId=138988, objectId=5ac3138988db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ac3138988db, replyNumber=0, likeNumber=77, createdTime=2018-06-26, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ac3138988db, moduleTitle=Neurology：病例：Creutzfeldt-Jakob病的DWI和脑电图表现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ac3138988db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737985, encodeId=b2871e3798596, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Circulation：JAK-STAT信号抑制剂可抑制大中动脉血管炎的病理性免疫反应, objectType=article, longId=137057, objectId=aa2113e057ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa2113e057ee, replyNumber=0, likeNumber=69, createdTime=2018-12-26, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa2113e057ee, moduleTitle=Circulation：JAK-STAT信号抑制剂可抑制大中动脉血管炎的病理性免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa2113e057ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737989, encodeId=08511e37989fd, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=IGLH：JAK2或CALR突变的共存是骨髓增生性肿瘤临床上重要的事件？, objectType=article, longId=139536, objectId=a6da1395367c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6da1395367c, replyNumber=0, likeNumber=101, createdTime=2018-10-14, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6da1395367c, moduleTitle=IGLH：JAK2或CALR突变的共存是骨髓增生性肿瘤临床上重要的事件？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6da1395367c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737977, encodeId=829e1e3797741, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Br J Dermatol：JTE-052，一种Jak3抑制剂，治疗特应性皮炎安全且有效, objectType=article, longId=115913, objectId=b12811591349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b12811591349, replyNumber=0, likeNumber=50, createdTime=2018-07-25, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b12811591349, moduleTitle=Br J Dermatol：JTE-052，一种Jak3抑制剂，治疗特应性皮炎安全且有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b12811591349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737986, encodeId=b3bf1e37986f1, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Blood：B细胞在体外对IL-21的反应或可作为IL2RG/JAK3缺陷 SCID患者进行异基因造血干细胞移植后体液免疫的生物标志物, objectType=article, longId=137448, objectId=21c913e448d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21c913e448d2, replyNumber=0, likeNumber=80, createdTime=2018-06-24, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21c913e448d2, moduleTitle=Blood：B细胞在体外对IL-21的反应或可作为IL2RG/JAK3缺陷 SCID患者进行异基因造血干细胞移植后体液免疫的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21c913e448d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737983, encodeId=f5591e37983ee, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=FDA批准Lilly/Incyte的低剂量JAK抑制剂治疗类风湿性关节炎, objectType=article, longId=136407, objectId=f78d13640ef0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f78d13640ef0, replyNumber=0, likeNumber=63, createdTime=2019-01-31, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f78d13640ef0, moduleTitle=FDA批准Lilly/Incyte的低剂量JAK抑制剂治疗类风湿性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f78d13640ef0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737987, encodeId=6cc51e37987c9, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Blood：JAK2抑制剂芦可替尼上市后的思考, objectType=article, longId=138017, objectId=3e8713801eaf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e8713801eaf, replyNumber=0, likeNumber=58, createdTime=2018-11-01, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e8713801eaf, moduleTitle=Blood：JAK2抑制剂芦可替尼上市后的思考, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e8713801eaf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737981, encodeId=ba0e1e37981b3, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Blood：经典型霍奇金淋巴瘤的JAK-STAT信号通路的基因普遍存在突变, objectType=article, longId=135310, objectId=616c135310d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=616c135310d1, replyNumber=0, likeNumber=95, createdTime=2019-02-22, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=616c135310d1, moduleTitle=Blood：经典型霍奇金淋巴瘤的JAK-STAT信号通路的基因普遍存在突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=616c135310d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737991, encodeId=8b541e3799147, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率, objectType=article, longId=141010, objectId=cb7914101089, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb7914101089, replyNumber=0, likeNumber=34, createdTime=2018-10-22, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb7914101089, moduleTitle=Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb7914101089)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737979, encodeId=c7181e37979d4, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Blood：原发性纵膈大B细胞淋巴瘤的体细胞IL4R突变，激活JAK-STAT信号通路, objectType=article, longId=130399, objectId=be3a13039929, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be3a13039929, replyNumber=0, likeNumber=117, createdTime=2018-12-03, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be3a13039929, moduleTitle=Blood：原发性纵膈大B细胞淋巴瘤的体细胞IL4R突变，激活JAK-STAT信号通路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be3a13039929)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

JAK

2020-05-29

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

礼来JAK抑制剂Olumiant治疗系统性红斑狼疮的2期临床试验获得成功

2019-04-23

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Stem cells：JAK2V617F突变型巨核细胞可通过促血小板生成素/MPL信号促进造血干/祖细胞扩增

2018-11-21

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

JCC： JAK激酶抑制剂Peficitinib在治疗中重度UC中有良好效果

2019-01-25

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

CLIN CANCER RES：MET致癌活化和JAK2失活会影响肺癌PD-L1表达

2019-07-02

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Blood：PI3Kδ抑制剂（INCB040093）单独或联合JAK1抑制剂（itacitinib）用于复发性/难治性B细胞淋巴瘤的安全性和疗效研究

2018-09-19

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Blood：JAK2抑制剂用于治疗骨髓增生性肿瘤（MFN）的效果和安全性评估

2018-06-24

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

NEJM：扎心了！治疗骨髓纤维化的JAK2抑制剂竟会导致淋巴瘤！

2018-08-15

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状

2018-12-13

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Blood：Jak2V617F协同Dnmt3a缺失通过激活增强子驱动的炎症信号诱导骨髓纤维化

2019-09-13

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

瑞石生物开展新型JAK1抑制剂全球同步临床研究

2019-05-12

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Neurology：病例：Creutzfeldt-Jakob病的DWI和脑电图表现

2018-06-26

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Circulation：JAK-STAT信号抑制剂可抑制大中动脉血管炎的病理性免疫反应

2018-12-26

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

IGLH：JAK2或CALR突变的共存是骨髓增生性肿瘤临床上重要的事件？

2018-10-14

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Br J Dermatol：JTE-052，一种Jak3抑制剂，治疗特应性皮炎安全且有效

2018-07-25

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Blood：B细胞在体外对IL-21的反应或可作为IL2RG/JAK3缺陷 SCID患者进行异基因造血干细胞移植后体液免疫的生物标志物

2018-06-24

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

FDA批准Lilly/Incyte的低剂量JAK抑制剂治疗类风湿性关节炎

2019-01-31

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Blood：JAK2抑制剂芦可替尼上市后的思考

2018-11-01

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Blood：经典型霍奇金淋巴瘤的JAK-STAT信号通路的基因普遍存在突变

2019-02-22

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率

2018-10-22

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Blood：原发性纵膈大B细胞淋巴瘤的体细胞IL4R突变，激活JAK-STAT信号通路

2018-12-03

科室
- - 订阅+
  - 更多科室
工具
服务